Matregenix

Matregenix is a materials science company specializing in the design, development, and manufacturing of highly tunable nanofibrous materials. Founded in 2018 in Boston, Massachusetts, by Dr. Sherif Soliman, a material scientist with over 20 years of experience in biomaterials and nanofibers, the company initially focused on developing biomaterial implants. In 2019, Matregenix relocated to Irvine, California, and expanded its focus to include filtration technology, notably producing filter media for N95 respirators in response to the COVID-19 pandemic. The company has since expanded into a 10,000-square-foot manufacturing facility in Mission Viejo, California, featuring clean rooms for clinical-grade manufacturing and fully equipped laboratories.

The company operates through two primary divisions: Biomedical and Filtration. The Biomedical division concentrates on creating solutions for wound healing, tissue engineering scaffolds, regenerative medicine, and drug delivery systems. A key product in this division is MatriNova, a synthetic, antimicrobial fiber matrix that mimics the human extracellular matrix to facilitate tissue regeneration without the risk of disease transmission associated with biological materials. Another product is DermaSpin, a handheld device that sprays a wound dressing onto a patient without contact. The Filtration division develops high-performance nanofibrous membranes for air and water filtration, personal protective equipment (PPE), and industrial applications like HVAC systems.

Matregenix's business model includes providing contract development and manufacturing (CDMO) services, guiding clients from concept and prototyping to large-scale production. The company utilizes its proprietary MGX Hybrid and TURBO spinning electrospinning technology, which allows for scalable and cost-effective production of nanofiber materials. This has reportedly made Matregenix the largest nanofiber supplier in the United States. The firm has been largely self-funded through revenue from its contract services and has received grant funding from entities including the National Institutes of Health and the Department of Defense through AFWERX.

Keywords: nanofiber technology, electrospinning, biomaterials, filtration media, tissue engineering, regenerative medicine, contract manufacturing, wound healing, medical devices, air filtration, water purification, advanced materials, drug delivery, PPE, synthetic scaffolds, nanomanufacturing, CDMO services, material science, clinical-grade manufacturing, defense applications